NASDAQ:FONR - Fonar Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $22.25 -0.33 (-1.46 %) (As of 11/16/2018 02:07 PM ET)Previous Close$22.58Today's Range$22.18 - $22.6152-Week Range$21.20 - $30.10Volume951 shsAverage Volume24,368 shsMarket Capitalization$138.59 millionP/E Ratio6.96Dividend YieldN/ABeta1.42 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York. Receive FONR News and Ratings via Email Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FONR Previous Symbol CUSIPN/A Webwww.fonar.com Phone631-694-2929 Debt Debt-to-Equity RatioN/A Current Ratio5.99 Quick Ratio4.51 Price-To-Earnings Trailing P/E Ratio6.96 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$81.52 million Price / Sales1.74 Cash Flow$3.8628 per share Price / Cash5.76 Book Value$16.82 per share Price / Book1.32 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$21.23 million Net Margins23.56% Return on Equity20.53% Return on Assets17.86% Miscellaneous Employees525 Outstanding Shares6,360,000Market Cap$138.59 million OptionableNot Optionable Fonar (NASDAQ:FONR) Frequently Asked Questions What is Fonar's stock symbol? Fonar trades on the NASDAQ under the ticker symbol "FONR." How were Fonar's earnings last quarter? Fonar Co. (NASDAQ:FONR) posted its earnings results on Thursday, September, 13th. The medical equipment provider reported $1.44 earnings per share for the quarter. The medical equipment provider had revenue of $21.04 million for the quarter. Fonar had a net margin of 23.56% and a return on equity of 20.53%. View Fonar's Earnings History. When is Fonar's next earnings date? Fonar is scheduled to release their next quarterly earnings announcement on Monday, February 11th 2019. View Earnings Estimates for Fonar. Has Fonar been receiving favorable news coverage? News stories about FONR stock have trended positive this week, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Fonar earned a news impact score of 2.8 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an impact on the stock's share price in the immediate future. Who are some of Fonar's key competitors? Some companies that are related to Fonar include Viewray (VRAY), Cutera (CUTR), Rockwell Medical (RMTI), BioLife Solutions (BLFS), Electrocore (ECOR), Semler Scientific (SMLR), Zynex (ZYXI), Second Sight Medical Products (EYES), Stereotaxis (STXS), Edap Tms (EDAP), IRIDEX (IRIX), Viveve Medical (VIVE), Soleno Therapeutics (SLNO), Digirad (DRAD) and ENDRA Life Sciences (NDRA). Who are Fonar's key executives? Fonar's management team includes the folowing people: Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 82)Mr. Timothy R. Damadian, CEO & Pres (Age 54)Mr. Luciano B. Bonanni, COO & Exec. VP (Age 63)Ms. Claudette J. V. Chan, Sec. & Director (Age 80)Mr. Daniel Culver, Director of Communications Who are Fonar's major shareholders? Fonar's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (7.79%), BlackRock Inc. (5.37%), LSV Asset Management (4.61%), Dimensional Fund Advisors LP (4.61%), Wells Fargo & Company MN (1.26%) and JPMorgan Chase & Co. (0.98%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar. Which institutional investors are selling Fonar stock? FONR stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, LSV Asset Management, Seizert Capital Partners LLC, BlackRock Inc., Bailard Inc., Panagora Asset Management Inc., Wells Fargo & Company MN and Bowling Portfolio Management LLC. Company insiders that have sold Fonar company stock in the last year include Raymond V Damadian and Robert J Janoff. View Insider Buying and Selling for Fonar. Which institutional investors are buying Fonar stock? FONR stock was acquired by a variety of institutional investors in the last quarter, including Matarin Capital Management LLC, Renaissance Technologies LLC, Dimensional Fund Advisors LP, Assenagon Asset Management S.A., Strs Ohio, First Trust Advisors LP, Trexquant Investment LP and Bank of New York Mellon Corp. View Insider Buying and Selling for Fonar. How do I buy shares of Fonar? Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Fonar's stock price today? One share of FONR stock can currently be purchased for approximately $22.25. How big of a company is Fonar? Fonar has a market capitalization of $138.59 million and generates $81.52 million in revenue each year. Fonar employs 525 workers across the globe. What is Fonar's official website? The official website for Fonar is http://www.fonar.com. How can I contact Fonar? Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected] MarketBeat Community Rating for Fonar (NASDAQ FONR)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 83 (Vote Outperform)Underperform Votes: 85 (Vote Underperform)Total Votes: 168MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe FONR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FONR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/16/2018 by MarketBeat.com StaffFeatured Article: What is an Initial Public Offering (IPO)?